Based in New York, InnovaHealth Partners, LP is a leading private equity firm providing growth capital to the medical technology industry. The firm focuses on a diversified portfolio of lead investment positions and collaborates closely with each management team. InnovaHealth Partners is led by five principals who collectively have over 100 years of experience investing in the medical device space. The team has worked together for over 15 years and has managed over $1 billion of committed capital between its funds and co-investments. For more information, please visit https://www.innovahealthpartners.com/
Norwest is a leading venture and growth equity investment firm managing more than $12.5 billion in capital. Since its inception, Norwest has invested in more than 650 companies and currently partners with more than 200 companies in its venture and growth equity portfolio. The firm invests in early to late-stage businesses across a wide range of sectors with a focus on consumer, enterprise, and healthcare. The Norwest team offers a deep network of connections, operating experience, and a wide range of impactful services to help CEOs and founders scale their businesses. Norwest has offices in Menlo Park and San Francisco, with subsidiaries in India and Israel. For more information, please visit www.nvp.com. Follow Norwest on Twitter @NorwestVP.
U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 500 companies spanning four decades, including: Arkose Labs, Box, Carrot Fertility, Cato Networks, Check Point Software, Guidewire, Happy Returns, HeartFlow, HotelTonight, Human Interest, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Kenna, Medigate, Omada Health, Pluto TV, Standard Bariatrics, ThreatMetrix, Trunk Club, Trusteer, Yammer and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California. https://www.usvp.com/
For more than 30 years,the principals of The Vertical Group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry’s most successful companies including: American Medical Systems, Cardiovascular Imaging Systems, Cardio Thoracic Systems, EP Technologies, Intermedics, Kyphon Corporation, OEC Medical, SciMed Life Systems, Support Systems International, Ventana Medical Systems, Wright Medical Group, and Xomed Surgical Products. The Vertical Group’s principals are active in National Venture Capital Association (NVCA) activities and were among the founders of the Association’s Medical Industry Group.
The Vertical Group is the successor to the venture capital division of F. Eberstadt & Co. and has been an independent firm since 1988. In 1992 The Vertical Group expanded the scope of its investment activities in a merger with Paddington Partners, a firm engaged in special situation investments, primarily public health care equities. The Vertical Group is headquartered in Basking Ridge, New Jersey, and has an office in Palo Alto, California. https://www.vertical-group.com
Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation, one of the world’s largest philanthropic enterprise foundations. Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S, and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Principal Investments, Planetary Health Investments and Asia teams, Novo Holdings invests in life science companies at all stages of development. For more information, please visit https://novoholdings.dk/.